160 related articles for article (PubMed ID: 18567865)
1. How promiscuity promotes tolerance: the case of myasthenia gravis.
Kyewski B; Taubert R
Ann N Y Acad Sci; 2008; 1132():157-62. PubMed ID: 18567865
[TBL] [Abstract][Full Text] [Related]
2. The thymus medulla slowly yields its secrets.
Tykocinski LO; Sinemus A; Kyewski B
Ann N Y Acad Sci; 2008 Nov; 1143():105-22. PubMed ID: 19076347
[TBL] [Abstract][Full Text] [Related]
3. Self-representation in the thymus: an extended view.
Kyewski B; Derbinski J
Nat Rev Immunol; 2004 Sep; 4(9):688-98. PubMed ID: 15343368
[TBL] [Abstract][Full Text] [Related]
4. Promiscuous gene expression in the thymus: the root of central tolerance.
Magalhães DA; Silveira EL; Junta CM; Sandrin-Garcia P; Fachin AL; Donadi EA; Sakamoto-Hojo ET; Passos GA
Clin Dev Immunol; 2006; 13(2-4):81-99. PubMed ID: 17162352
[TBL] [Abstract][Full Text] [Related]
5. Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms.
Ströbel P; Chuang WY; Chuvpilo S; Zettl A; Katzenberger T; Kalbacher H; Rieckmann P; Nix W; Schalke B; Gold R; Müller-Hermelink HK; Peterson P; Marx A
Ann N Y Acad Sci; 2008; 1132():143-56. PubMed ID: 18567864
[TBL] [Abstract][Full Text] [Related]
6. Highly variable expression of tissue-restricted self-antigens in human thymus: implications for self-tolerance and autoimmunity.
Taubert R; Schwendemann J; Kyewski B
Eur J Immunol; 2007 Mar; 37(3):838-48. PubMed ID: 17323415
[TBL] [Abstract][Full Text] [Related]
7. An acetylcholine receptor alpha subunit promoter confers intrathymic expression in transgenic mice. Implications for tolerance of a transgenic self-antigen and for autoreactivity in myasthenia gravis.
Salmon AM; Bruand C; Cardona A; Changeux JP; Berrih-Aknin S
J Clin Invest; 1998 Jun; 101(11):2340-50. PubMed ID: 9616205
[TBL] [Abstract][Full Text] [Related]
8. Expression of tumor-associated differentiation antigens, MUC1 glycoforms and CEA, in human thymic epithelial cells: implications for self-tolerance and tumor therapy.
Cloosen S; Arnold J; Thio M; Bos GM; Kyewski B; Germeraad WT
Cancer Res; 2007 Apr; 67(8):3919-26. PubMed ID: 17440107
[TBL] [Abstract][Full Text] [Related]
9. Genetic factors in autoimmune myasthenia gravis.
Giraud M; Vandiedonck C; Garchon HJ
Ann N Y Acad Sci; 2008; 1132():180-92. PubMed ID: 18567868
[TBL] [Abstract][Full Text] [Related]
10. Thymus-dependent T cell tolerance of neuroendocrine functions: principles, reflections, and implications for tolerogenic/negative self-vaccination.
Geenen V
Ann N Y Acad Sci; 2006 Nov; 1088():284-96. PubMed ID: 17192574
[TBL] [Abstract][Full Text] [Related]
11. [Development of the thymus and immune system].
Matsui N; Nitta T; Takahama Y
Brain Nerve; 2011 Jul; 63(7):679-84. PubMed ID: 21747137
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune regulator controls T cell help for pathogenetic autoantibody production in collagen-induced arthritis.
Campbell IK; Kinkel SA; Drake SF; van Nieuwenhuijze A; Hubert FX; Tarlinton DM; Heath WR; Scott HS; Wicks IP
Arthritis Rheum; 2009 Jun; 60(6):1683-93. PubMed ID: 19479827
[TBL] [Abstract][Full Text] [Related]
13. Regulating self-tolerance by deregulating gene expression.
Gotter J; Kyewski B
Curr Opin Immunol; 2004 Dec; 16(6):741-5. PubMed ID: 15511667
[TBL] [Abstract][Full Text] [Related]
14. An IRF8-binding promoter variant and AIRE control CHRNA1 promiscuous expression in thymus.
Giraud M; Taubert R; Vandiedonck C; Ke X; Lévi-Strauss M; Pagani F; Baralle FE; Eymard B; Tranchant C; Gajdos P; Vincent A; Willcox N; Beeson D; Kyewski B; Garchon HJ
Nature; 2007 Aug; 448(7156):934-7. PubMed ID: 17687331
[TBL] [Abstract][Full Text] [Related]
15. The thymus and myasthenia gravis.
Ragheb S; Lisak RP
Chest Surg Clin N Am; 2001 May; 11(2):311-27, x. PubMed ID: 11413758
[TBL] [Abstract][Full Text] [Related]
16. Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients.
Luther C; Adamopoulou E; Stoeckle C; Brucklacher-Waldert V; Rosenkranz D; Stoltze L; Lauer S; Poeschel S; Melms A; Tolosa E
J Immunol; 2009 Jul; 183(2):841-8. PubMed ID: 19542375
[TBL] [Abstract][Full Text] [Related]
17. [Antibodies to an antigen of human thymus epithelial tissue common to the epidermis of the skin in malignant myasthenia].
Gnezditskaia EV; Beletskaia LV; Shagal DI
Biull Eksp Biol Med; 1977 Jan; 83(1):60-2. PubMed ID: 322757
[TBL] [Abstract][Full Text] [Related]
18. Regulatory and pathogenic mechanisms in human autoimmune myasthenia gravis.
Le Panse R; Cizeron-Clairac G; Cuvelier M; Truffault F; Bismuth J; Nancy P; De Rosbo NK; Berrih-Aknin S
Ann N Y Acad Sci; 2008; 1132():135-42. PubMed ID: 18567863
[TBL] [Abstract][Full Text] [Related]
19. Central tolerance: essential for preventing autoimmune disease?
von Boehmer H
Eur J Immunol; 2009 Sep; 39(9):2313-6. PubMed ID: 19714571
[TBL] [Abstract][Full Text] [Related]
20. Infrequent and low AIRE expression in thymoma: difference in AIRE expression among WHO subtypes does not correlate with association of MG.
Suzuki E; Kobayashi Y; Yano M; Fujii Y
Autoimmunity; 2008 Aug; 41(5):377-82. PubMed ID: 18568643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
